Skip to main content


Fig. 8 | BMC Medicine

Fig. 8

From: Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

Fig. 8

Ethanolamine concentration as a single metabolic biomarker predicting the overall survival in patients with PA. a ROC and b Kaplan-Meier curves obtained from the analysis of ethanolamine concentrations for the diagnosis of long-term survival in patients with PA. The AUC was 0.861 ± 0.101, the threshold value was 0.740 nmol/mg, and sensitivity and specificity were, respectively, equal to 77.80% and 75.00%. The Kaplan-Meier curve shows differences between long-term and short-term survival patients. The p value was 0.005 (for the log-rank test)

Back to article page